- Home
- MYFW vs AVTX Comparison
MYFW vs AVTX Comparison
Compare MYFW & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYFW
- AVTX
- Stock Information
- Founded
- MYFW 2002
- AVTX 2011
- Country
- MYFW United States
- AVTX United States
- Employees
- MYFW 321
- AVTX N/A
- Industry
- MYFW Major Banks
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MYFW Finance
- AVTX Health Care
- Exchange
- MYFW Nasdaq
- AVTX Nasdaq
- Market Cap
- MYFW 216.2M
- AVTX 248.3M
- IPO Year
- MYFW 2018
- AVTX 2015
- Fundamental
- Price
- MYFW $22.46
- AVTX $17.40
- Analyst Decision
- MYFW Buy
- AVTX Strong Buy
- Analyst Count
- MYFW 2
- AVTX 9
- Target Price
- MYFW $24.25
- AVTX $30.14
- AVG Volume (30 Days)
- MYFW 25.0K
- AVTX 450.4K
- Earning Date
- MYFW 10-23-2025
- AVTX 11-06-2025
- Dividend Yield
- MYFW N/A
- AVTX N/A
- EPS Growth
- MYFW 226.95
- AVTX N/A
- EPS
- MYFW 1.18
- AVTX N/A
- Revenue
- MYFW $93,514,000.00
- AVTX $441,000.00
- Revenue This Year
- MYFW $14.41
- AVTX N/A
- Revenue Next Year
- MYFW $12.25
- AVTX N/A
- P/E Ratio
- MYFW $18.85
- AVTX N/A
- Revenue Growth
- MYFW 16.68
- AVTX N/A
- 52 Week Low
- MYFW $17.10
- AVTX $3.39
- 52 Week High
- MYFW $24.88
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- MYFW 46.62
- AVTX 75.89
- Support Level
- MYFW $22.05
- AVTX $13.60
- Resistance Level
- MYFW $23.62
- AVTX $15.99
- Average True Range (ATR)
- MYFW 0.53
- AVTX 1.32
- MACD
- MYFW -0.06
- AVTX 0.18
- Stochastic Oscillator
- MYFW 24.56
- AVTX 98.03
About MYFW First Western Financial Inc.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).